Inventor · disambiguated record
Nilesh Zaware
Also filed as: ZAWARE NILESH · ZAWARE NILESH K
6 granted patents·5 pending applications·0 citations·filing 2014–2023
63Inventor score
Top patents by PatentIndex Score
11 records- 0162US9884806B2Cyclic vinylogous amides as bromodomain inhibitorsICAHN SCHOOL MED MOUNT SINAI·Filed 2014·Granted Feb 6, 2018·0 cites·20 claims
- 0252US2025388575A1Heterobifunctional compounds and methods of treating diseaseHALDA THERAPEUTICS OPCO INC·Filed 2023·Application pending·0 cites
- 0352US2024238424A1Heterobifunctional compounds and methods of treating diseaseHALDA THERAPEUTICS OPCO INC·Filed 2023·Application pending·0 cites
- 0452US2025388605A1Heterobifunctional compounds and methods of treating diseaseHALDA THERAPEUTICS OPCO INC·Filed 2023·Application pending·0 cites
- 0550US2025136619A1Heterobifunctional compounds and their use in treating diseaseHALDA THERAPEUTICS OPCO INC·Filed 2022·Application pending·0 cites
- 0647US10351511B2Cyclic vinylogous amides as bromodomain inhibitorsICAHN SCHOOL MED MOUNT SINAI·Filed 2017·Granted Jul 16, 2019·0 cites·18 claims
- 0747US2024408093A1Heterobifunctional compounds and their use in treating diseaseHALDA THERAPEUTICS OPCO INC·Filed 2022·Application pending·0 cites
- 0845US12473263B2Bicyclic inhibitors of CBX chromodomainsICAHN SCHOOL MED MOUNT SINAI·Filed 2020·Granted Nov 18, 2025·0 cites·7 claims
- 0937US10759790B2Heterocyclic constrained tricyclic sulfonamides as anti-cancer agentsICAHN SCHOOL MED MOUNT SINAI·Filed 2016·Granted Sep 1, 2020·0 cites·20 claims
- 1037US10450282B2Stereospecific process for 3-heterocyclylcycloaliphatic-1,2-diolsICAHN SCHOOL MED MOUNT SINAI·Filed 2016·Granted Oct 22, 2019·0 cites·12 claims
- 1135US10221158B2Heterocyclic constrained tricyclic sulfonamides as anti-cancer agentsICAHN SCHOOL MED MOUNT SINAI·Filed 2016·Granted Mar 5, 2019·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Nilesh Zaware files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →